Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 103403193 | 10340319 | 3 | F | 20140702 | 20160916 | 20140724 | 20160921 | EXP | GB-MHRA-EYC 00112938 | GB-PFIZER INC-2014202150 | PFIZER | 71.00 | YR | M | Y | 110.00000 | KG | 20160921 | PH | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 103403193 | 10340319 | 1 | PS | IBUPROFEN. | IBUPROFEN | 1 | Oral | 400 MG, 3X/DAY (400 MG, TID PRN) | 18000 | MG | Y | 18989 | 400 | MG | TID | ||||
| 103403193 | 10340319 | 2 | SS | XARELTO | RIVAROXABAN | 1 | Oral | 10 MG, 1X/DAY (10 MG, QD) | 150 | MG | Y | 0 | 10 | MG | QD | ||||
| 103403193 | 10340319 | 3 | C | BENDROFLUMETHIAZIDE | BENDROFLUMETHIAZIDE | 1 | UNK | 0 | |||||||||||
| 103403193 | 10340319 | 4 | C | CHLORPHENAMINE | CHLORPHENIRAMINE MALEATE | 1 | UNK | 0 | |||||||||||
| 103403193 | 10340319 | 5 | C | DOXAZOSIN | DOXAZOSINDOXAZOSIN MESYLATE | 1 | UNK | 0 | |||||||||||
| 103403193 | 10340319 | 6 | C | FEXOFENADINE | FEXOFENADINEFEXOFENADINE HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 103403193 | 10340319 | 7 | C | METOCLOPRAMIDE. | METOCLOPRAMIDE | 1 | UNK | 0 | |||||||||||
| 103403193 | 10340319 | 8 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | UNK | 0 | |||||||||||
| 103403193 | 10340319 | 9 | C | PREDNISOLONE. | PREDNISOLONE | 1 | UNK | 0 | |||||||||||
| 103403193 | 10340319 | 10 | C | SIMVASTATIN. | SIMVASTATIN | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 103403193 | 10340319 | 1 | Analgesic therapy |
| 103403193 | 10340319 | 2 | Thrombosis prophylaxis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 103403193 | 10340319 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 103403193 | 10340319 | Diarrhoea | |
| 103403193 | 10340319 | Erythema multiforme | |
| 103403193 | 10340319 | Eye swelling | |
| 103403193 | 10340319 | Hypersensitivity | |
| 103403193 | 10340319 | Lip swelling | |
| 103403193 | 10340319 | Swelling face | |
| 103403193 | 10340319 | Urticaria |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 103403193 | 10340319 | 1 | 20140617 | 0 | ||
| 103403193 | 10340319 | 2 | 20140617 | 0 |